Myocardial infarction (MI) is one of the main factors in heart failure (HF) progression. New
Spasov, AA,
Kucheryavenko, AF,
Khaliullin, FA,
Gurova, NA,
Sirotenko, VS,
Samorodov, AV,
Gaidukova, KA,
Pavlov, VN (2022) comorbidities and with isoproterenol-induced
myocardial infarction. In animals without comorbidities, Angipur
TCTAP C-025 EMBOLIC
MYOCARDIAL INFARCTION CAUSED BY LEFT ATRIUM EMBOLI FROM ATRIAL FIBRILLATION
Yagudin, T.,
Zhao, Y.,
Gao, H.,
Zhang, Y.,
Yang, Y.,
Zhang, X.,
Ma, W.,
Daba, T.M.,
Ishmetov, V.,
Kang, K.,
Yang, B.,
Pan, Z. (2020) of this study was to investigate the possible role of iASPP in acute
myocardial infarction. The protein level
Yagudin, T,
Zhao, Y,
Gao, HY,
Zhang, Y,
Yang, Y,
Zhang, XF,
Ma, WB,
Daba, TM,
Ishmetov, V,
Kang, K,
Yang, BF,
Pan, ZW (2021) of this study was to investigate the possible role of iASPP in acute
myocardial infarction. The protein level